Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,167,085
+$1,784,205 QoQ
Shares Held
445,277
+42.6% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. RDY ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,167,085 | 445,277 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,382,880 | 312,171 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,631,301 | 188,219 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,925,423 | 194,639 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,995,646 | 227,115 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,229,868 | 331,214 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,847,599 | 73,601 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,947,461 | 91,186 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,245,805 | 98,784 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,914,230 | 84,999 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,588,232 | 98,523 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,021,388 | 95,411 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,161,639 | 73,101 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,535,904 | 106,974 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,026,061 | 115,133 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,620,655 | 119,528 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,694,864 | 138,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,214,556 | 156,162 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,027,609 | 199,994 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,225,478 | 179,914 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,663,486 | 189,990 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,338,302 | 173,072 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,800,570 | 184,022 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,450,762 | 197,147 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $11,192,380 | 277,520 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||